Baird Medical falls short of Nasdaq minimum bid price requirement
BDMD•Baird Medical received a Nasdaq deficiency notice for failing the $1 minimum bid price requirement. It has until May 3, 2027, to regain compliance by closing at or above $1 for 10 consecutive business days; trading continues uninterrupted in the meantime.
1. Compliance deadline
Baird Medical received a Nasdaq deficiency notice dated November 2, 2026, after failing the $1 minimum bid price requirement. The company has 180 calendar days, until May 3, 2027, to regain compliance by having its ordinary shares close at a bid price of at least $1 for 10 consecutive business days.
2. Trading continues
The shares continue trading uninterrupted on the Nasdaq Capital Market under ticker BDMD, and the notice has no immediate effect on the listing. Failure to comply could trigger delisting, though an additional 180-day grace period may be available subject to Nasdaq requirements.
